Revolution Medicines, Inc. Warrant
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Revolution Medicines, Inc. Warrant generated cash of -$350,572,000, which is less than the previous year. Cash used in financing activities reached the amount of $1,229,200,000 last year. Net change in cash is therefore $536,030,000.

Cash Flow

Revolution Medicines, Inc. Warrant (NASDAQ:RVMDW): Cash Flow
2017 -25.14M -1.57M 22.66M
2019 -49.61M -101.96M 98.65M
2022 -224.40M -24.11M 301.43M
2023 -350.57M -342.59M 1.22B

RVMDW Cash Flow Statement (2017 – 2023)

2023 2022 2019 2017
Cash at beginning of period
163.14M110.23M69.8M13.14M
Operating activities
Net income
-436.36M-248.70M-47.66M-31.12M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
9.30M9.65M3.34M1.18M
Stock-based compensation expense
61.77M31.19M3.16M141K
Deferred income tax benefit 61.77M31.19M3.16M141K
Changes in operating assets and liabilities:
Accounts receivable, net
3.41M1.25M-1.43M0
Inventories
001.43M0
Accounts payable
32.46M7.28M5.26M1.96M
Cash generated by operating activities
-350.57M-224.40M-49.61M-25.14M
Investing activities
Purchases Of Investments
-1.05B-612.76M-172.26M0
Investments In Property Plant And Equipment
-7.72M-10.81M-2.58M-1.57M
Acquisitions Net
013.3M196K0
Cash generated by investing activities
-342.59M-24.11M-101.96M-1.57M
Financing activities
Common Stock Issued
385.75M298.04M100.02M74K
Payments for dividends
0000
Repurchases of common stock
3.31M0-45K0
Repayments of term debt
0000
Cash used in financing activities
1.22B301.43M98.65M22.66M
Net Change In Cash
536.03M52.91M-52.92M-4.06M
Cash at end of period
699.17M163.14M16.87M9.07M
Data sourceData sourceData source